Pharming Group (PHAR)
8.490
+0.46
(+5.73%)
USD |
NASDAQ |
Sep 27, 16:00
8.49
0.00 (0.00%)
After-Hours: 20:00
Pharming Group Revenue (Annual): 245.32M for Dec. 31, 2023
Revenue (Annual) Chart
Historical Revenue (Annual) Data
| Date | Value |
|---|---|
| December 31, 2023 | 245.32M |
| December 31, 2022 | 205.62M |
| December 31, 2021 | 198.87M |
| December 31, 2020 | 212.17M |
| December 31, 2019 | 189.39M |
| December 31, 2018 | 154.58M |
| December 31, 2017 | 107.52M |
| December 31, 2016 | 16.69M |
| December 31, 2015 | 11.84M |
| December 31, 2014 | 25.76M |
| Date | Value |
|---|---|
| December 31, 2013 | 9.451M |
| December 31, 2012 | 14.04M |
| December 31, 2011 | 3.887M |
| December 31, 2010 | 0.7621M |
| December 31, 2009 | 0.48M |
| December 31, 2008 | 0.9244M |
| December 31, 2007 | 1.006M |
| December 31, 2006 | 0.194M |
| December 31, 2005 | 0.4797M |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (Annual) Range, Past 5 Years
189.39M
Minimum
2019
245.32M
Maximum
2023
210.27M
Average
205.62M
Median
2022
Revenue (Annual) Benchmarks
| uniQure NV | 15.84M |
| ProQR Therapeutics NV | 7.052M |
| Merus NV | 43.95M |
| argenx SE | 1.226B |
| Pharvaris NV | -- |